José Luís Molinuevo

Author

José Luís Molinuevo

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ORCID

Also Known As

A Torre, Camara, Oscar, Carles Falcón, Carlo Miniussi, Chris Lynch, Frederik Barkhof, Gemma Salvadó, J L Molinuevo, J Molinuevo, J. L Molinuevo

777

Publications

59.7K

Citations

105

H-Index

192

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital Clínic de Barcelona Pasqual Maragall Foundation Barcelonaβeta Brain Research Center University College London

About

José Luís Molinuevo is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	76	10.7K
2	Health Sciences	14	15	770
3	Language Studies	3	3	470
4	Nursing	2	2	595
5	Engineering	1	1	25

José Luís Molinuevo

299

Publications

32K

Citations

H-Index

Page 1

	Year	Citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria Bruno Dubois, Howard Feldman, Claudia Jacova, The Lancet Neurology NeuropsychologyAlzheimer's DiseaseDementiaResearch Diagnostic CriteriaBiomarkers	2014	3.2K
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, Alzheimer s & Dementia	2024	1.7K
Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study Álex Iranzo, José Luís Molinuevo, Joan Santamaría, The Lancet Neurology Sleep DisordersSleepNeuropsychologyDescriptive StudySleep Disorder	2006	950
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis Gernot Kleinberger, Yoshinori Yamanishi, Marc Suárez‐Calvet, Science Translational Medicine	2014	805
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study Álex Iranzo, Eduard Tolosa, Ellen Gelpí, The Lancet Neurology Sleep DisordersSleepNeurodegenerative DiseasesNeurobiology Of DiseaseSleep Disorder	2013	692
Dementia care during COVID-19 Huali Wang, Tao Li, Paola Barbarino, The Lancet NursingDementiaElderly CareDementia CareCovid-19	2020	582
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum Andréa Lessa Benedet, Marta Milà‐Alomà, Agathe Vrillon, JAMA Neurology	2021	566
Implementation of subjective cognitive decline criteria in research studies José Luís Molinuevo, Laura A. Rabin, Rebecca E. Amariglio, Alzheimer s & Dementia	2016	552
Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients Álex Iranzo, Ana Fernández‐Arcos, Eduard Tolosa, PLoS ONE	2014	515
<scp>sTREM</scp> 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers Marc Suárez‐Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, EMBO Molecular Medicine ImmunologyNeurochemical BiomarkersSocial SciencesNeuroinflammationCsf Levels	2016	503

Page 1